BROOKHAVEN SCIENCE ASSOCIATES

National Synchrotron Light Source II

Project ManagementJim Yeck

NLSL II Deputy Director (Project Management)

BROOKHAVEN SCIENCE ASSOCIATES

Overall Project Strategy

• Emphasis on schedule and critical path activities

• Schedule development currently not constrained by funding• Conventional facilities are on the critical path until 2010

• Relatively tight cost baseline with adequate contingency

• Strictly controlled and administered cost baseline• Roughly 35% overall project contingency at CD-1

• Provision for scope adjustments based on experience • Expect some scope restoration under normal market conditions• Some scope reductions (scope contingency) are also possible

BROOKHAVEN SCIENCE ASSOCIATES

Work Breakdown Structure

BROOKHAVEN SCIENCE ASSOCIATES

Milestones

DATE Milestone ActivityAug. 2005 CD0 Approve Mission Need; Commence Conceptual Design

Jan. 2006 Initiate EA, AE/CM Solicitation/Selection

Aug. 2006 Submit Acquisition Strategy, etc

Oct. 2006 Approve Acquisition Strategy; Approve EA & issue FONSI; Committee Reviews

Nov. 2006 Complete CDR, Preliminary Cost Estimate and Schedules

Dec. 2006 CD1 Lehman Review

Jan. 2007 CD1 Approve Alternate Selection and Cost Range; Commence Title I Design

Dec. 2007 CD2/CD3a Approve Performance Baseline; Commence Title II Design; Long Lead Procurements

Sep. 2008 CD3b Approve Start of construction

2009 Construction underway, 15 months to Linac “beneficial occupancy”.

2011 Installation and subsystem integration.

2013 CD4a/CD4b Complete construction, installation, and commissioning. Begin operations.

Summary Schedule

BROOKHAVEN SCIENCE ASSOCIATES

“Notional” Funding Profile

(in $ millions)

FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 Totals

Other Project Costs 1 4.8 25 20 5 4 10 20 46.2 136Project Engineering and Design 20 42.5 2.5 65

Long-Lead Procurement 10 10

Construction 127 165 150 100 47 589Totals 1 4.8 45 72.5 134.5 169 160 120 93.2 800

Note: Funding in FY05-FY07 is actual. The funding profile for FY08 and later is notional and will depend on the annual appropriation process.

BROOKHAVEN SCIENCE ASSOCIATES

Funding vs. Requirements

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

160.0

180.0

200.0

FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14Fiscal Year

Fund

ing

(AY

M$)

Original FundingProfile

Present FundingProfile

Current Estimate

BROOKHAVEN SCIENCE ASSOCIATES

Next Steps

• Finalize scope, cost estimate, and contingency estimates• Scope definition and WBS dictionary clarification• Bottoms-up risk assessment and contingency estimates

• Complete schedule development• Improve schedule logic and general technical realism

• Consider advice of internal advisory committees

• Establish resource and funding requirements